Rob Hart

Rob Hart has made 22 investments in companies such as: Precision NanoSystem, TrakCel, Nimble Therapeutics, Estech, RareCyte, PneumRx, BioVentrix, Aquaro Histology, AngioScore, LDR Holding, Asuragen, Confirma, Accumetrics, Nivagen Pharmaceuticals, Inc., Freedom Innovations LLC., Althea Technologies, AltheaDx, Medpricer, Specific Diagnostics, Akoya Biosciences, Emerging Therapy Solutions, Carterra.

Location of Rob Hart is San Francisco, United States.

The free version of Angel Match provides limited data for Rob Hart. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.

Rob Hart is a Partner and he his investment types are: Private Equity Firm.
Rob Hart focuses investing in industries such as: Biotechnology, Developer Platform, Medical, Manufacturing, Market Research, Pharmaceutical, Health Care, Life Science, Medical Device, Health Diagnostics, Insurance, Chemical, Therapeutics, Genetics, Information Technology, Robotics.

A short brief about investor:


Past investments

  • Precision NanoSystem
  • TrakCel
  • Nimble Therapeutics
  • Estech
  • RareCyte
  • PneumRx
  • BioVentrix
  • Aquaro Histology
  • AngioScore
  • LDR Holding
  • Asuragen
  • Confirma
  • Accumetrics
  • Nivagen Pharmaceuticals, Inc.
  • Freedom Innovations LLC.
  • Althea Technologies
  • AltheaDx
  • Medpricer
  • Specific Diagnostics
  • Akoya Biosciences
  • Emerging Therapy Solutions
  • Carterra

Social media:

Available after registration.